Literature DB >> 32541156

Treatment of Penile Prosthesis Implant's Infection.

Marco Cosentino1, Marta Bianco2, Eduard Ruiz-Castañé3, Massimo Iafrate2.   

Abstract

INTRODUCTION: Penile prosthesis implant is a safe and effective option in erectile dysfunction patients, being implant procedures safe with a low risk of infection. However, when infection occurs, it represents a concrete problem for both surgeon and patient.
METHODS: This is a comprehensive review of all issues relating to prosthesis infection, including causes and risk factors, methods of prevention, and management. We analyzed all preoperative and perioperative factors, which can play a role in infection of the device.
RESULTS: Infection of penile prosthesis implant is hard to manage and correct. While the incidence of infection following first implant is up to 3%, in cases of re-implant surgery, the rate can reach as high as 18%. Many articles were found addressing prevention and treatment of penile prosthesis infection, and many analyzed all relevant pre- and perioperative factors associated with penile prosthesis implant. Although such factors have been well studied, there is no clear consensus worldwide on certain topics.
CONCLUSIONS: Penile prosthesis implant is a safe and effective option. Despite infection is a rare event, surgeons should follow strictly pre-, intra- and postoperative recommendations in order to reduce the risk of device's infection. An appropriate antibiotic therapy should be tailored on patient's characteristics and pathogens isolated.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Infection; Penile prosthesis implant; Prosthesis explant; Prosthesis infection; Treatment infection

Mesh:

Year:  2020        PMID: 32541156     DOI: 10.1159/000508472

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  1 in total

1.  [Quality of life in patients who suffered erectile dysfunction and underwent penile implant surgery in terms of sexual satisfaction of the patient and partner].

Authors:  K-M Arndt; A Chomicz; K-P Jünemann; D Osmonov
Journal:  Urologe A       Date:  2020-12-23       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.